DateContentStatus
08/05/2024 Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23Updated
08/05/2024 Document: Timetable: Post-authorisation safety study (PASS) protocols and final resultsUpdated
08/05/2024 Page: Website outages and upgradesUpdated
08/05/2024 Document: Timetable: Initial (Full) marketing authorisation application - ATMPUpdated
07/05/2024 Document: Organisation chart: Advisory functionsUpdated
07/05/2024 Page: Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guidelineUpdated
07/05/2024 Medicine: Vaxzevria (previously COVID-19 Vaccine AstraZeneca)Updated
07/05/2024 Herbal: Hippocastani cortex - herbal medicinal productUpdated
07/05/2024 News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2024Updated
07/05/2024 Page: PRIME: priority medicinesUpdated
07/05/2024 Document: List of medicines currently in PRIME schemeUpdated
07/05/2024 Medicine: EmblaveoUpdated
07/05/2024 Event: Product Management Service (PMS) Info-DayUpdated
07/05/2024 Page: COVID-19 vaccines: key factsUpdated
06/05/2024 Document: Record of data processing activity relating to Security Access Control System (public)Updated
06/05/2024 Document: European Medicines Agency’s privacy statement for the operation of the Security Access Control SystemUpdated
06/05/2024 Page: ProcurementUpdated
06/05/2024 Event: EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcomaUpdated
06/05/2024 Referral: Synapse - referralUpdated
06/05/2024 Medicine: AdynoviUpdated
06/05/2024 Medicine: AdvateUpdated
06/05/2024 Document: Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modificationUpdated
06/05/2024 Document: List of signals discussed at PRAC since September 2012Updated
03/05/2024 Medicine: MenQuadfiUpdated
03/05/2024 PIP: EMEA-002754-PIP01-19 - paediatric investigation planUpdated
03/05/2024 PIP: EMEA-002693-PIP01-19 - paediatric investigation planUpdated
03/05/2024 PIP: EMEA-003157-PIP01-21 - paediatric investigation planUpdated
03/05/2024 PIP: EMEA-001666-PIP01-14-M01 - paediatric investigation planUpdated
03/05/2024 Document: Agenda - Joint HMA/EMA Big Data Steering Group Workshop on RWE methodsUpdated
03/05/2024 Document: Agenda - Twelfth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicinesUpdated
03/05/2024 Event: Third European Medicines Agency and Affordable Medicines Europe bilateral meetingUpdated
03/05/2024 Medicine: BriumviUpdated
03/05/2024 Document: Sponsors' guide: Transition of trials from EudraCT to CTIS - CTIS Training Programme - Module 23Updated
03/05/2024 Medicine: TevimbraUpdated
03/05/2024 Medicine: SivextroUpdated
03/05/2024 Medicine: TalzennaUpdated
03/05/2024 Page: ICH M10 on bioanalytical method validation - Scientific guidelineUpdated
03/05/2024 Page: Plasma master file certificatesUpdated
03/05/2024 Page: Big dataUpdated
02/05/2024 Document: Template for scientific document (part B-F)Updated
02/05/2024 Document: Scientific recommendations on classification of advanced therapy medicinal productsUpdated
02/05/2024 Document: Appendix 1: Acceptable intakes established for N-nitrosaminesUpdated
02/05/2024 Page: Information ManagementUpdated
02/05/2024 Herbal: Malvae sylvestris flos - herbal medicinal productUpdated
02/05/2024 Medicine: PelmegUpdated
02/05/2024 Medicine: NoxafilUpdated
02/05/2024 Medicine: Teriflunomide AccordUpdated
02/05/2024 Medicine: ByoovizUpdated
02/05/2024 Medicine: PluvictoUpdated
02/05/2024 Medicine: RotaTeqUpdated
02/05/2024 Medicine: TracleerUpdated
02/05/2024 Medicine: StayveerUpdated
02/05/2024 Medicine: VolibrisUpdated
02/05/2024 Herbal: Malvae folium - herbal medicinal productUpdated
02/05/2024 Medicine: VafseoUpdated
02/05/2024 Medicine: IncellipanUpdated
02/05/2024 Page: Handling competing interestsUpdated
02/05/2024 Medicine: CelldemicUpdated
02/05/2024 Medicine: ZynyzUpdated
02/05/2024 Page: Quality of medicines questions and answers: Part 1Updated
02/05/2024 Page: Stability testing for applications for variations to a marketing authorisation for veterinary medicinal products - Scientific guidelineUpdated
02/05/2024 Medicine: MirapexinUpdated
02/05/2024 Document: List of eligible industry stakeholder organisationsUpdated